Drug · DIN 00012696
DALMANE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 8, 2016; first marketed December 31, 1971.
- Drug Identification Number (DIN)
- 00012696
- Company (DIN owner)
- Valeant Canada LpLaval, Quebec, Canada
- Schedule
- Targeted substances (CDSA IV)
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Flurazepam N05CD01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FLURAZEPAM HYDROCHLORIDE | 15 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 16, 2005: NOC 6805New Drug Submission (NDS) · Manufacturer name change
- December 21, 1998: NOC 2884New Drug Submission (NDS) · Manufacturer name change
Other DINs named DALMANE
- DIN 00012718 · Cancelled Post Market